Lacm.Kl

LACM.KL maintains a relatively strong liquidity position, with a current ratio of 2.11, indicating the company can cover its short-term liabilities with its short-term assets. However, the company has a negative net cash position after subtracting total debt, which raises liquidity concerns. The company's debt-to-equity ratio is 0.23, suggesting a conservative capital structure with limited leverage.

In terms of profitability, LACM.KL reports a return on equity (ROE) of 18.5% and a return on assets (ROA) of 10.22%, both of which are strong indicators of efficient use of equity and assets. These figures suggest the company is generating solid returns relative to its capital base. Gross profit of MYR 58.57 million and operating income of MYR 31.76 million further support the company's profitability.

The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, such as regulatory changes or shifts in healthcare demand. The lack of geographic diversification could limit the company's ability to offset regional downturns.

LACM.KL's growth trajectory is not explicitly detailed in the available data, but the company's operating cash flow of MYR 376,350 and free cash flow of MYR 13.75 million suggest it has the capacity to reinvest in the business or return value to shareholders. The capital expenditure of MYR -9.46 million indicates the company is reducing its investment in long-term assets, which may signal a focus on cost control or a shift in strategic priorities.

The company faces a medium liquidity risk, as highlighted by the risk assessment, and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, indicating potential challenges in maintaining liquidity without external financing. No dilution sources are explicitly identified in the available data, and the dilution risk is assessed as low.

Recent events and filings do not provide specific details on the company's operations or strategic direction. The analyst estimates suggest a neutral outlook, with a mean recommendation of 2.00 (1=strong buy, 5=strong sell) and a mean price target of MYR 1.14. The lack of strong buy or hold recommendations indicates a cautious stance among analysts.